LB PHARMACEUTICALS INC (LBRX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$36.91

From 52W high−21.56%

Volume588378.00

Market cap$1.25B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$36.91

From 52W high

−21.56%

Volume

588378.00

Market cap

$1.25B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.6x

P/E (TTM)

—

RSI (14)

52.4

MomentumView details →

1D Return

+5.63%

YTD Return

+75.86%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−10.6x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

3.8x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−25.78%

ROA (TTM)

−23.69%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+94.39%

EBITDA YoY

—

MomentumView details →

1D Return

+5.63%

YTD Return

+75.86%

1Y Return

+144.67%

RSI (14)

52.4

vs 50D SMA

−8.19%

vs 200D SMA

+23.50%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

15.08x

Quick Ratio

15.08x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$1.71

EPS Surprise

−112.78%

Beats (12Q)

1/12

Next Q EPS Est

−$1.66

Avg Surprise (4Q)

−27.28%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−85.69M

Op. CF (TTM)

−82.39M

Next earningsNov 5, 2026 →

Latest newsMore news →

LB Pharmaceuticals announced it will host an in-person and virtual R&D Day on October 27, 2026, focused on advancing LB-102 for schizophrenia treatment.14d ago

LB Pharmaceuticals Inc appointed Susan G. Kozauer, M.D. as Chief Medical Officer effective September 14, 2026.35d ago

Similar companies

Nektar TherapeuticsNKTR GH Research PLCGHRS ST嘉必优688089.SH Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.02566.HK ImmuneOnco Biopharmaceuticals (Shanghai) Inc.01541.HK Taysha Gene Therapies, Inc.TSHA Find similar companies →

Latest newsMore news →

LB Pharmaceuticals announced it will host an in-person and virtual R&D Day on October 27, 2026, focused on advancing LB-102 for schizophrenia treatment.14d ago LB Pharmaceuticals Inc appointed Susan G. Kozauer, M.D. as Chief Medical Officer effective September 14, 2026.35d ago